(MENAFN- GlobeNewsWire - Nasdaq) itemprop="articleBody">
Stockholm, December 19, 2018— Nasdaq (Nasdaq: NDAQ) announces that the trading in CombiGene AB's shares (short name: COMBI) will commence today on Nasdaq First North in Stockholm. CombiGene belongs to the health care sector and is the 83rd company to be admitted to trading on Nasdaq's Nordic markets* in 2018.
MENAFN1912201800703653ID1097853222
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.